Phaseline

Companies › Ayu

Ayu: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 1; Metabolic and endocrine.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
VELGRAFT
Allogeneic cell-based product containing bone marrow-derived mesenchymal stem cells (MSCs)
–Phase 1Diabetic Foot Ulcer (DFU)–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT07498218VELGRAFTPhase 1Diabetic Foot Ulcer (DFU)Metabolic and endocrineOct 2026

Targets

No annotated target.

Companies with the same targets

–

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.